Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Celyad SA Stock Forecast NASDAQ:CYAD
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-01-11 | 469.95% | Wells Fargo | $20.00 $11.00 | Maintains | Overweight |
| 2021-08-06 | 677.2% | HC Wainwright & Co. | $17.00 $15.00 | Maintains | Buy |
| 2021-05-10 | 780.83% | HC Wainwright & Co. | $18.00 $17.00 | Maintains | Buy |
| 2021-03-26 | - | JonesTrading | - | Downgrades | Buy Hold |
| 2020-12-08 | 832.64% | HC Wainwright & Co. | $22.00 $18.00 | Maintains | Buy |
| 2020-03-26 | 936.27% | Wells Fargo | $44.00 $20.00 | Maintains | Overweight |
| 2020-03-25 | 1817.1% | HC Wainwright & Co. | $43.00 $37.00 | Maintains | Buy |
CYAD Stock Trend
The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.87, a level that may pose a second chance to hit a runner. According to fan-theory $2.69 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $1.05 | $1.46 | $1.86 |
| 2022-05-24 | $1.04 | $1.44 | $1.85 |
| 2022-05-25 | $1.02 | $1.43 | $1.84 |
| 2022-05-26 | $1.01 | $1.42 | $1.82 |
| 2022-05-27 | $1.00 | $1.41 | $1.81 |
| 2022-05-31 | $0.99 | $1.39 | $1.80 |
| 2022-06-01 | $0.97 | $1.38 | $1.79 |
| 2022-06-02 | $0.96 | $1.37 | $1.77 |
| 2022-06-03 | $0.95 | $1.35 | $1.76 |
| 2022-06-06 | $0.94 | $1.34 | $1.75 |
| 2022-06-07 | $0.92 | $1.33 | $1.73 |
| 2022-06-08 | $0.91 | $1.32 | $1.72 |
| 2022-06-09 | $0.90 | $1.30 | $1.71 |
| 2022-06-10 | $0.89 | $1.29 | $1.70 |
| 2022-06-13 | $0.87 | $1.28 | $1.68 |
| 2022-06-14 | $0.86 | $1.27 | $1.67 |
| 2022-06-15 | $0.85 | $1.25 | $1.66 |
| 2022-06-16 | $0.84 | $1.24 | $1.65 |
| 2022-06-17 | $0.82 | $1.23 | $1.63 |
| 2022-06-21 | $0.81 | $1.22 | $1.62 |
| 2022-06-22 | $0.80 | $1.20 | $1.61 |
| 2022-06-23 | $0.78 | $1.19 | $1.60 |
| 2022-06-24 | $0.77 | $1.18 | $1.58 |
| 2022-06-27 | $0.76 | $1.17 | $1.57 |
| 2022-06-28 | $0.75 | $1.15 | $1.56 |
| 2022-06-29 | $0.73 | $1.14 | $1.55 |
| 2022-06-30 | $0.72 | $1.13 | $1.53 |
| 2022-07-01 | $0.71 | $1.11 | $1.52 |
| 2022-07-05 | $0.70 | $1.10 | $1.51 |
| 2022-07-06 | $0.68 | $1.09 | $1.49 |
Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company offers C-Cure, an autologous cell therapy for the treatment of heart failure. It also provides NKR-2, an autologous chimeric antigen receptor (CAR), a lab engineered receptor for the treatment of cancer. In addition, the companys p... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
